The report highlights Eurofarma's commitment to sustainability, including its commitment to neutralizing 100% of direct CO₂ emissions, its focus on renewable energy sources, and its efforts to promote access to healthcare for all. The company also highlights its commitment to social responsibility, including its work through the Eurofarma Institute and its efforts to combat the COVID-19 pandemic. Eurofarma also highlights its commitment to innovation, with a focus on radical innovation and the development of new medicines, and its commitment to fostering a culture of equity and inclusion. The report also includes a comprehensive overview of the company's financial performance, its environmental performance, and its social performance.
Issuing Company Eurofarma Laboratorios S.A.
Report Type Integrated Report
Report Language EN
Report Filesize 10.87 MB
No. of Pages 55 pages
Reporting periodJanuary 1, 2020-December 31, 2020
Report EditionUnknown
Assurance Provider KPMG Assessores Ltda.
Reporting Standards GRI; SASB; UNSDG
Materiality Assessmenttrue